NCT05778253View on ClinicalTrials.gov

The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

September 23, 2028

Study Completion Date

September 23, 2029

Conditions
Lung Squamous Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

WES and ctDNA detection

WES and ctDNA detection

Trial Locations (1)

410011

RECRUITING

Department of Thoracic Surgery, Second Xiangya Hospital of Central South University, China, Changsha

All Listed Sponsors
collaborator

Shanghai OrigiMed Co., Ltd.

UNKNOWN

lead

Second Xiangya Hospital of Central South University

OTHER